CannTrust: 2018 Licensed Producer of the Year Winner

CannTrust is a licensed producer of medical and recreational cannabis in Canada. Founded by pharmacists, CannTrust brings more than 40 years of pharma …

CannTrust Licensed Producer cannabis

CannTrust was voted Licensed Producer of the Year at the 2018 Canadian Cannabis Awards.

CannTrust is a licensed producer of medical and recreational cannabis in Canada. Founded by pharmacists, CannTrust brings more than 40 years of pharmaceutical and healthcare experience to the medical cannabis industry. Currently, it serves over 60,000 medical patients with its dried, extract and capsule products.

The Company operates its own facility, the 450,000 sq. ft. Niagara Perpetual Harvest Facility, while preparation and packaging of their broadest portfolio happen in Vaughan, Ontario, in a 60,000 sq.ft. facility.

Research and Innovation

CannTrust is developing nanotechnology to elaborate new products for the medical, recreational, beauty, wellness and pet markets.

In partnership with McMaster University in Ontario and Gold Coast University in Australia, the company contributes to research regarding the use and efficacy of cannabis.

To reach the international market, they searched a partnership with Cannatrek Ltd. and a joint venture with Stenocare in Australia. They also partnered with Breakthru Beverage Group through Kindred Canada for recreational distribution in Canada.

For more information on CannTrust (TRST:TSX) please fill out the form below.

No items found.

You might also like

Ivan Bebek on Where the Biggest Mining Returns May Still Lie
Metals & Mining
March 4, 2026

Ivan Bebek on Where the Biggest Mining Returns May Still Lie

Veteran mining entrepreneur Ivan Bebek believes the current gold and silver cycle may only be getting started.

This is some text inside of a div block.
Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine
Health & Wellness
March 3, 2026

Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine

Advanced heart failure continues to rise globally, while the supply of donor hearts remains limited. This structural imbalance creates a significant and expanding market opportunity, with thousands of patients each year lacking viable treatment options and placing growing economic pressure on healthcare systems.

This is some text inside of a div block.
BMO ETFs Highlights Simplicity and Low Cost in Asset Allocation ETFs
ETFs
March 3, 2026

BMO ETFs Highlights Simplicity and Low Cost in Asset Allocation ETFs

In Canada, management fees for asset allocation ETFs can range from approximately 50 basis points down to 15 basis points.

This is some text inside of a div block.
Subscribe and receive the investor Info